Kenichi Nomoto

Person

Belmont, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Multikinase inhibitors for use in the treatment of cancer
- Patent number 11,160,783
- Issue date Nov 2, 2021
- Eisai R&D Management Co., Ltd.
- Sergei Agoulnik
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of eribulin and lenvatinib as combination therapy for treatment...
- Patent number 9,549,922
- Issue date Jan 24, 2017
- Eisai R&D Management Co., Ltd.
- Kenichi Nomoto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multikinase inhibitors for use in the treatment of cancer
- Patent number 8,937,056
- Issue date Jan 20, 2015
- Eisai R&D Management Co., Ltd.
- Sergei Agoulnik
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multikinase inhibitors for use in the treatment of cancer
- Patent number 8,609,640
- Issue date Dec 17, 2013
- Eisai, Inc.
- Sergei Agoulnik
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
THERAPEUTIC AGENT FOR BILE DUCT CANCER
- Publication number 20190111043
- Publication date Apr 18, 2019
- National Cancer Center
- Tatsuhiro SHIBATA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTIKINASE INHIBITORS FOR USE IN THE TREATMENT OF CANCER
- Publication number 20180353468
- Publication date Dec 13, 2018
- Eisai R&D Management Co., Ltd.
- Sergei Agoulnik
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC AGENT FOR BILE DUCT CANCER
- Publication number 20180015079
- Publication date Jan 18, 2018
- National Cancer Center
- Tatsuhiro SHIBATA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR PROGNOSING THE ABILITY OF A ZEARALENONE ANALOG COMPOUND...
- Publication number 20160291027
- Publication date Oct 6, 2016
- Eisai R&D Management Co., Ltd.
- Kenichi NOMOTO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MULTIKINASE INHIBITORS FOR USE IN THE TREATMENT OF CANCER
- Publication number 20150182496
- Publication date Jul 2, 2015
- Eisai R&D Management Co., Ltd.
- Sergei Agoulnik
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF ERIBULIN AND LENVATINIB AS COMBINATION THERAPY FOR TREATMENT...
- Publication number 20150005343
- Publication date Jan 1, 2015
- Eisai R&D Management Co., Ltd.
- Kenichi NOMOTO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTIKINASE INHIBITORS FOR USE IN THE TREATMENT OF CANCER
- Publication number 20130303489
- Publication date Nov 14, 2013
- Eisai R&D Management Co., Ltd.
- Sergei Agoulnik
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for prognosing the ability of a zearalenone analog compound...
- Publication number 20090170925
- Publication date Jul 2, 2009
- Eisai R&D Management Co., Ltd.
- Kenichi Nomoto
- G01 - MEASURING TESTING
Information Patent Application
Multikinase Inhibitors for Use in the Treatment of Cancer
- Publication number 20090082313
- Publication date Mar 26, 2009
- Eisai R&D Management Co., Ltd.
- Sergei Agoulnik
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Kenichi Nomoto

Person

Patents Grantslast 30 patents

Multikinase inhibitors for use in the treatment of cancer

Use of eribulin and lenvatinib as combination therapy for treatment...

Multikinase inhibitors for use in the treatment of cancer

Multikinase inhibitors for use in the treatment of cancer

Patents Applicationslast 30 patents

THERAPEUTIC AGENT FOR BILE DUCT CANCER

MULTIKINASE INHIBITORS FOR USE IN THE TREATMENT OF CANCER

THERAPEUTIC AGENT FOR BILE DUCT CANCER

METHODS FOR PROGNOSING THE ABILITY OF A ZEARALENONE ANALOG COMPOUND...

MULTIKINASE INHIBITORS FOR USE IN THE TREATMENT OF CANCER

USE OF ERIBULIN AND LENVATINIB AS COMBINATION THERAPY FOR TREATMENT...

MULTIKINASE INHIBITORS FOR USE IN THE TREATMENT OF CANCER

Methods for prognosing the ability of a zearalenone analog compound...

Multikinase Inhibitors for Use in the Treatment of Cancer